centchroman has been researched along with Cancer of Cervix in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chauhan, N; Chauhan, SC; Hafeez, BB; Jaggi, M; Maher, DM; Mandil, H; Singh, MM; Yallapu, MM | 1 |
| B Hafeez, B; Chauhan, N; Chauhan, SC; Jaggi, M; Maher, DM; Singh, MM; Yallapu, MM | 1 |
2 other study(ies) available for centchroman and Cancer of Cervix
| Article | Year |
|---|---|
Ormeloxifene nanotherapy for cervical cancer treatment.
Topics: Animals; Benzopyrans; Carcinogenesis; Cell Line, Tumor; Cell Membrane; Cell Proliferation; Cell Survival; Clone Cells; Disease Models, Animal; Endocytosis; Erythrocytes; Female; Hemolysis; Humans; Materials Testing; Membrane Potential, Mitochondrial; Mice, Nude; Nanoparticles; Polylactic Acid-Polyglycolic Acid Copolymer; Serum; Uterine Cervical Neoplasms | 2019 |
A triphenylethylene nonsteroidal SERM attenuates cervical cancer growth.
Topics: Animals; Antineoplastic Agents; Apoptosis; Benzopyrans; Carcinogenesis; Cell Line, Tumor; Drug Repositioning; Female; G1 Phase Cell Cycle Checkpoints; Humans; Membrane Potential, Mitochondrial; Mice; Mice, Nude; Papillomavirus E7 Proteins; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays | 2019 |